---
title: "Axsome Therapeutics Inc. to Participate in Wells Fargo Healthcare Conference Fireside Chat"
description: "Axsome Therapeutics Inc., a biopharmaceutical company, will participate in the Wells Fargo Healthcare Conference on September 3, 2025. The company is scheduled to present during a fireside chat at 3:4"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/254788987.md"
published_at: "2025-08-27T11:00:16.000Z"
---

# Axsome Therapeutics Inc. to Participate in Wells Fargo Healthcare Conference Fireside Chat

> Axsome Therapeutics Inc., a biopharmaceutical company, will participate in the Wells Fargo Healthcare Conference on September 3, 2025. The company is scheduled to present during a fireside chat at 3:45 p.m. ET in Boston, MA. This announcement was originally published via GlobeNewswire on August 27, 2025.

Axsome Therapeutics Inc., a biopharmaceutical company focusing on central nervous system disorders, is set to participate in the Wells Fargo Healthcare Conference on September 3, 2025. The company will present during a fireside chat at 3:45 p.m. ET in Boston, MA. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Axsome Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9518497-en) on August 27, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT)

### Related Stocks

- [AXSM.US - Axsome Therap](https://longbridge.com/en/quote/AXSM.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Axsome Therap｜8-K：2025 财年 Q4 营收 1.96 亿美元超过预期 |  | [Link](https://longbridge.com/en/news/272266317.md) |
| MoneyShow 2026 年顶级推荐：Axsome Therapeutics Inc. (AXSM) | MoneyShow 2026 年最佳选择：Axsome Therapeutics Inc. (AXSM) | [Link](https://longbridge.com/en/news/273526371.md) |
| Axsome Therapeutics 首席执行官 Herriot Tabuteau 报告出售普通股 | Axsome Therapeutics 首席执行官 Herriot Tabuteau 报告了公司普通股的处置。完整的文件可通过提供的链接获取。此消息由 Public Technologies 生成，仅供参考，不应被视为财务、投资或法律建议 | [Link](https://longbridge.com/en/news/274570327.md) |
| 2026 年顶级推荐：Axsome Therapeutics Inc | Axsome Therapeutics Inc.（AXSM）正受到关注，因为它有三款产品上市，并且销售增长显著。用于治疗重度抑郁症的 Auvelity 在第三季度的销售增长了 69%，其峰值销售潜力估计为 20 亿美元。其他产品包括 Sun | [Link](https://longbridge.com/en/news/273591375.md) |
| Axsome Therapeutics 的首席财务官 Nick Pizzie 报告出售普通股 | Axsome Therapeutics Inc. 的首席财务官 Nick Pizzie 报告了该公司普通股的出售。完整的文件可通过提供的链接获取。此消息由 Public Technologies 生成，仅供参考，不应被视为财务、投资或法律建 | [Link](https://longbridge.com/en/news/273565682.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.